Literature DB >> 10743988

Degeneration of the acetabular cartilage in osteonecrosis of the femoral head: histopathologic examination of 15 hips.

G I Im1, D Y Kim, J H Shin, W H Cho, C J Lee.   

Abstract

Acetabular cartilage with subchondral bone was taken from the superior dome from 15 hips of 13 patients undergoing total hip arthroplasty due to osteonecrosis of the femoral head. The mean age of the patients was 40 years. There were 10 hips ARCO stage IIIA, and 5 hips stage IIIB. 3 of the cases were mild, 12 moderate, and 1 had severe arthrosis. The degree of collapse of the femoral head was significantly related to the degeneration of the acetabular cartilage on histological examination. Our observations support the view that patients with an ARCO Stage III hip do not benefit from head-preserving procedures. They may also explain why bipolar prosthesis gives poorer results than total hip arthroplasty, in cases of osteonecrosis of the femoral head.

Entities:  

Mesh:

Year:  2000        PMID: 10743988     DOI: 10.1080/00016470052943847

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  4 in total

Review 1.  Atraumatic Femoral Head Necrosis in Adults.

Authors:  Dariusch Arbab; Dietmar Pierre König
Journal:  Dtsch Arztebl Int       Date:  2016-01-22       Impact factor: 5.594

Review 2.  [Resurfacing for osteonecrosis of the femoral head].

Authors:  M Akbar; M A Mont; C Heisel; D R Marker; S D Ulrich; T M Seyler
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

Review 3.  [Bone marrow edema and atraumatic necrosis of the femoral head : Therapy].

Authors:  J Beckmann; A Roth; C Niethard; F Mauch; R Best; U Maus
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

4.  The expression of chondrogenesis-related and arthritis-related genes in human ONFH cartilage with different Ficat stages.

Authors:  Gaoyang Chen; Lei Zhong; Qingyu Wang; Zhaoyan Li; Jing Shang; Qiwei Yang; Zhenwu Du; Jincheng Wang; Yang Song; Guizhen Zhang
Journal:  PeerJ       Date:  2019-01-16       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.